Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

Daily Management, Symptom Control & The Care Team

At a Glance

Familial Alzheimer-like prion disease has no cure, so daily care focuses on personalized symptom relief, swallowing and fall safety, coordinated neurology and palliative support, emergency planning, and early goals-of-care discussions.

While receiving a diagnosis of familial Alzheimer-like prion disease is deeply challenging, it marks the beginning of a shift from searching for answers to focusing on your loved one’s comfort. Although there is currently no cure, specialized palliative care—medical care focused on relieving symptoms rather than curing the underlying disease—is a crucial component of management [1][2]. Palliative care can continue alongside active neurology and rehabilitation.

Managing Symptoms at Home

Because genetic prion diseases can affect everything from movement to mood, your doctor may consider a combination of medications to keep your loved one comfortable. Because these diseases are rare, there is no “one-size-fits-all” regimen; treatment is highly individualized, and you should never start, stop, or change doses without explicit clinician guidance [1][3].

  • Motor Symptoms: For muscle jerks (myoclonus) or stiffness (parkinsonism), medications such as benzodiazepines (like clonazepam) or anticonvulsants (like sodium valproate) may be considered by the treating clinician [1][4]. Warning: These drugs can cause heavy sedation, falls, confusion, dependence, and respiratory suppression. While typical Parkinson’s drugs (like levodopa) lack broad evidence, a supervised trial may be reasonable in selected parkinsonian syndromes [5].
  • Neuropsychiatric Symptoms: If your loved one experiences severe anxiety, agitation, or hallucinations, low doses of antipsychotics or benzodiazepines are sometimes utilized [1]. Warning: Antipsychotics have additional dementia-related mortality and cardiovascular warnings; drug choice and dosing depend heavily on swallowing status, alertness, and goals of care.
  • Autonomic Issues: In mutations like Y157X, your team may need to manage non-brain symptoms such as chronic nausea, digestive issues, or sudden drops in blood pressure when standing (postural hypotension) [6][7].

Building Your Care Team

Managing this condition requires a village. A multidisciplinary team ensures that all aspects of the disease—physical, emotional, and genetic—are addressed [8].

  • Neurologist or Neurogeneticist: Ideally someone with experience in prion diseases to oversee the medical course.
  • Palliative Care Specialist: They focus on “quality of life” and help manage pain, sleep, and the emotional toll on both the patient and caregiver [2].
  • Physical and Occupational Therapists, and Social Work: Help with home safety, mobility, driving considerations, respite care, and social support.
  • Speech-Language Pathologist (SLP): This is a critical team member who evaluates swallowing (dysphagia). They recommend individualized food and liquid strategies, positioning, and oral care. Note that thickened liquids do not eliminate the risk of aspiration pneumonia, and they can reduce enjoyment and hydration [9].
  • Genetic Counselor: Essential for helping other family members understand their own risks and options for testing [10][11].

Knowing When to Call for Emergency Help

As the disease progresses, it can be difficult to tell the difference between “normal” decline and a genuine medical emergency. While gradual decline is expected, new, worsening, or distressing symptoms should be reported to the clinical team, as they may indicate a treatable condition like dehydration, pain, or medication side effects.

What is a Medical Emergency?

These situations require immediate medical assessment:

  • Aspiration or Airway Issues: If your loved one is choking severely, unable to protect their airway, or develops a sudden fever and “wet” sounding cough (signs of aspiration pneumonia) [12][9].
  • New or Severe Seizures: Any first-time seizure or a seizure that lasts longer than five minutes or repeats without the person waking up in between [13][4].
  • Sudden, Rapid Change: A sudden inability to maintain intake, severe medication reactions, or a dramatic drop in ability over just a few hours [13][14].

What is Routine Progression?

These changes are expected parts of the disease, though you should still notify your neurologist:

  • Gradual worsening of memory or confusion over weeks or months.
  • Slowly increasing difficulty with walking, balance, or coordination.
  • The appearance of occasional muscle jerks or “twitches” (myoclonus).

Planning for the Future

Because cognitive decline can happen more quickly than expected, establishing advance directives early is one of the most empowering things a family can do [8][2]. Discussing goals of care—such as preferences for feeding tubes, hospitalization, or hospice (whose eligibility depends on goals and prognosis rather than a fixed point)—ensures that your loved one’s wishes are honored even when they can no longer speak for themselves [2][15].

Common questions in this guide

How is familial Alzheimer-like prion disease managed day to day?
There is currently no cure, so care centers on comfort, safety, and relief of symptoms. A neurologist, palliative-care clinician, and rehabilitation team may tailor medicines and supportive therapies to the person's symptoms and goals. Medicines should not be started, stopped, or changed without the treating clinician's guidance.
What can help with muscle jerks, stiffness, anxiety, or hallucinations?
Clinicians may consider medicines such as clonazepam or sodium valproate for muscle jerks or stiffness, and carefully selected low-dose medicines for severe anxiety, agitation, or hallucinations. These drugs can cause sleepiness, falls, confusion, dependence, breathing problems, or other serious effects, so the choice and dose must be individualized.
Who should be part of the care team?
Care may involve a neurologist or neurogeneticist, palliative-care specialist, physical and occupational therapists, social work, and a speech-language pathologist. A genetic counselor can help relatives understand inherited risk and testing options. The team should coordinate care around the person's symptoms, safety, and goals.
How can we reduce swallowing and aspiration risks?
A speech-language pathologist can assess swallowing and recommend personalized food and liquid strategies, positioning, and mouth care. Thickened liquids may be useful for some people but do not remove the risk of food or liquid entering the airway, and they can reduce enjoyment or hydration.
Which symptoms require immediate emergency help?
Seek immediate medical assessment for severe choking or inability to protect the airway, a first seizure, a seizure lasting more than five minutes, repeated seizures without waking, or a sudden major decline over hours. A new fever with a wet-sounding cough, inability to maintain food or fluid intake, or a severe medication reaction also needs urgent attention. Ask the treating team whether a rescue-medication plan is appropriate; do not use or change such medicine without instructions.
When should palliative care or hospice be discussed?
Palliative care can begin while neurology and rehabilitation continue because it helps with symptoms, quality of life, and caregiver support. Hospice should be discussed when it fits the person's goals and expected course; eligibility is based on goals and prognosis rather than one fixed stage.
Why should we make advance directives and discuss goals of care early?
Cognitive decline may progress faster than expected, so early planning can document preferences about hospitalization, feeding tubes, hospice, and who should make decisions. These conversations help the care team honor the person's wishes if they can no longer communicate them.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which symptoms should we prioritize treating now—myoclonus, anxiety, or motor stiffness—and what medications do you recommend for them?
  2. 2.Can we have a speech-language pathologist perform a swallowing assessment to establish a 'baseline' and prevent aspiration?
  3. 3.At what point should we consider transitioning from outpatient neurology to home-based palliative care or hospice?
  4. 4.What is the risk of my loved one developing seizures, and should we have 'rescue medications' on hand at home?
  5. 5.If an emergency occurs, should we go to the nearest ER or contact your team first?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Prion diseases motor and neuropsychiatric symptom cluster pharmacotherapy: structured scoping review.

    Hogg R, Centola J, McDermott EA, et al.

    BMJ supportive & palliative care 2024; (14(e3)):e2397-e2410 doi:10.1136/spcare-2024-005027.

    PMID: 39060092
  2. 2

    Palliative Care Resource Utilization in Patients With Prion Disease.

    Zayat R, Piura YD, Appleby BS, et al.

    Neurology 2025; (105(6)):e214076 doi:10.1212/WNL.0000000000214076.

    PMID: 40893060
  3. 3

    Insights into the Diagnosis, Treatment, and Management of Prion Diseases.

    Callista VA, Hatware KV, Ingle PV

    CNS & neurological disorders drug targets 2026; (25(1)):25-38 doi:10.2174/0118715273381241250620114740.

    PMID: 40635224
  4. 4

    Gerstmann-Sträussler-Scheinker disease: A case report.

    Zhao MM, Feng LS, Hou S, et al.

    World journal of clinical cases 2019; (7(3)):389-395 doi:10.12998/wjcc.v7.i3.389.

    PMID: 30746381
  5. 5

    Dopaminergic neurodegeneration in Gerstmann-Sträussler-Scheinker (P102L) disease: insights from imaging and pathological examination.

    Irie KI, Honda H, Tateishi T, et al.

    Frontiers in neurology 2024; (15()):1452709 doi:10.3389/fneur.2024.1452709.

    PMID: 39376689
  6. 6

    A new prion disease: relationship with central and peripheral amyloidoses.

    Mead S, Reilly MM

    Nature reviews. Neurology 2015; (11(2)):90-7 doi:10.1038/nrneurol.2014.263.

    PMID: 25623792
  7. 7

    Fatal familial insomnia and Agrypnia Excitata: Autonomic dysfunctions and pathophysiological implications.

    Baldelli L, Provini F

    Autonomic neuroscience : basic & clinical 2019; (218()):68-86 doi:10.1016/j.autneu.2019.02.007.

    PMID: 30890351
  8. 8

    Rapid Neurocognitive Deterioration and Mortality in a Healthcare Professional With Spongiform Encephalopathy: Implications for Neurologic and End-of-Life Care.

    Kortz MW, Kongs BM, Middleton LE

    Cureus 2021; (13(4)):e14277 doi:10.7759/cureus.14277.

    PMID: 33959455
  9. 9

    Swallowing Function Evaluation in a Patient with Gerstmann-Sträussler-Scheinker Disease with Pro105Leu: A Case Report.

    Nakane A, Hasegawa S, Ishii M, et al.

    International journal of environmental research and public health 2021; (18(18)) doi:10.3390/ijerph18189734.

    PMID: 34574659
  10. 10

    Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know.

    Schwartz M, Brandel JP, Babonneau ML, et al.

    Frontiers in genetics 2019; (10()):895 doi:10.3389/fgene.2019.00895.

    PMID: 31616476
  11. 11

    Genetic counseling for prion disease: Updates and best practices.

    Goldman JS, Vallabh SM

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(10)):1993-2003 doi:10.1016/j.gim.2022.06.003.

    PMID: 35819418
  12. 12

    Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease.

    Hayashi Y, Iwasaki Y, Waza M, et al.

    Prion 2020; (14(1)):109-117 doi:10.1080/19336896.2020.1739603.

    PMID: 32178563
  13. 13

    CJD mimics and chameleons.

    Mead S, Rudge P

    Practical neurology 2017; (17(2)):113-121 doi:10.1136/practneurol-2016-001571.

    PMID: 28153848
  14. 14

    Clinical and Radiological Deterioration in a Case of Creutzfeldt-Jakob Disease following SARS-CoV-2 Infection: Hints to Accelerated Age-Dependent Neurodegeneration.

    Ciolac D, Racila R, Duarte C, et al.

    Biomedicines 2021; (9(11)) doi:10.3390/biomedicines9111730.

    PMID: 34829958
  15. 15

    Gastrostomy in patients with prion disease.

    Iwasaki Y, Mori K, Ito M, et al.

    Prion 2017; (11(3)):186-194 doi:10.1080/19336896.2017.1306164.

    PMID: 28509623

This page is for informational purposes only and does not constitute medical advice. For medication changes, swallowing or emergency concerns, and palliative or hospice decisions, consult your loved one's neurology and care team.

Get notified when new evidence is published on Familial Alzheimer-like prion disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.